Cargando…
Histological remission of eosinophilic esophagitis under asthma therapy with IL-5 receptor monoclonal antibody: A case report
BACKGROUND: Benralizumab is a monoclonal antibody targeting the IL-5 receptor used in the treatment of asthma. The use of benralizumab in other conditions is only emerging and could represent a therapeutic option for other eosinophil-associated diseases. Here, we report the case of a patient sufferi...
Autores principales: | Huguenot, Marc, Bruhm, Anne-Catherine, Essig, Manfred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125258/ https://www.ncbi.nlm.nih.gov/pubmed/35663093 http://dx.doi.org/10.12998/wjcc.v10.i14.4502 |
Ejemplares similares
-
Systematic review of histological remission criteria in eosinophilic esophagitis
por: Eke, Ransome, et al.
Publicado: (2018) -
Usefulness of the Eosinophilic Esophagitis Histologic Scoring System in Distinguishing Active Eosinophilic Esophagitis From Remission and Gastroesophageal Reflux Disease
por: Lin, Bo, et al.
Publicado: (2021) -
The past, present, and future of monoclonal antibodies to IL-5 and eosinophilic asthma: a review
por: Patterson, Megan F, et al.
Publicado: (2015) -
Anti-IL5 Monoclonal Antibodies Reduce Asthma Exacerbations and Corticosteroids Dose in Three Eosinophilic Granulomatosis with Polyangiitis Case Reports
por: Skouvaklidou, Elpida, et al.
Publicado: (2023) -
Production of monoclonal antibodies reactive with ovine eosinophils
por: Sansome, Georgina M, et al.
Publicado: (2007)